Scientific American November 15, 2020
Brennan Spiegel

Depression and anxiety have risen amid the pandemic; immersive therapeutics can help

I am being challenged daily. As a frontline doctor, I find that the COVID-19 pandemic has not only tested my clinical abilities but also strained my capacity to bear witness to grievous suffering. This suffering extends well beyond the physical distress of hospitalized patients battling the virus. The pandemic has also spawned a mental health crisis beyond anything I have seen in 25 years of caring for patients. The statistics are overwhelming: CDC research indicates that 31 percent of Americans have reported anxiety and depression during the pandemic, and 11 percent have considered suicide. A national shortage in mental health clinicians existed before COVID-19. Now, health care...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Mental Health, Metaverse/VR, Patient / Consumer, Provider, Public Health / COVID, Technology
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired
FDA initiative puts AR/VR at heart of home health drive
Meta's Reality Labs posts $3.85 billion loss in first quarter
Meta Aims to Ignite Enterprise Productivity With Open Metaverse OS

Share This Article